ADPT

NASDAQ · Life Sciences Tools & Services

Adaptive Biotechnologies

Mid-Cap Stocks Healthcare Stocks

$14.27

+0.17 (+1.21%)

As of May 9, 1:27 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +504.1% upside

Low Target $68.90

Average Target $86.20

High Target $131.13

Current Price $14.27

Current
$14.27

Target
$86.20

$68.90 $86.20 avg $131.13

Scenario Analysis

Bear Case

$68.90

382.8%

Low target

Base Case

$86.20

+504.1%

Avg target

Bull Case

$131.13

+818.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$20.76

-31.3% from high

52-Week Low

$8.38

+70.4% from low

50-Day SMA

$16.81

-15.1% vs SMA

200-Day SMA

$13.88

+2.8% vs SMA

RSI (14)

24.2

Oversold

Target vs 52W High

$86.20

+315.2% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	34	88%	$369.21	-20.6%
DHR Danaher Corp	Strong Buy	30	87%	$158.11	-7.6%
WAT Waters Corp	Buy	28	57%	$189.60	-46.6%
A Agilent Technologies Inc	Strong Buy	28	79%	$64.69	-44.0%
IQV Iqvia Holdings Inc	Strong Buy	31	87%	$82.96	-53.6%
MTD Mettler-Toledo International	Hold	21	48%	$170.43	-84.8%
WST West Pharmaceutical Services	Strong Buy	23	78%	$136.24	-58.2%
ILMN Illumina Inc	Hold	28	54%	$169.36	+19.4%